Contineum Therapeutics is a clinical-stage biopharmaceutical company developing small molecule drug candidates for neuroinflammation and immunology (NI&I) indications. Its lead asset, PIPE-791, is an LPA1R antagonist in Phase 2 development for idiopathic pulmonary fibrosis (IPF) and Phase 1b for chronic pain. Its second candidate, PIPE-307, is a selective M1R antagonist developed in partnership with Johnson & Johnson for major depressive disorder and relapsing-remitting multiple sclerosis.
expected 2026-12-14
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-03-05 | 2025-12-31 | 0001628280-26-015165 | EDGAR | 96K words |
| 2025-03-06 | 2024-12-31 | 0001437749-25-006458 | EDGAR | 104K words |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-11-03 | 2026-09-30 | 0001628280-26-069515 | EDGAR | 61K words |
| 2026-07-30 | 2026-06-30 | 0001628280-26-051054 | EDGAR | 18K words |
| 2025-10-30 | 2025-09-30 | 0001437749-25-032427 | EDGAR | 22K words |
| 2025-08-05 | 2025-06-30 | 0001437749-25-024852 | EDGAR | 22K words |
| 2025-05-14 | 2025-03-31 | 0001437749-25-016835 | EDGAR | 19K words |
| 2024-11-06 | 2024-09-30 | 0001437749-24-033616 | EDGAR | 23K words |
| 2024-08-14 | 2024-06-30 | 0001437749-24-026680 | EDGAR | 22K words |
| 2024-05-16 | 2024-03-31 | 0001437749-24-017320 | EDGAR | 61K words |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2026-11-03 | 0001628280-26-069493 | EDGAR | 2K words |
| 2026-09-14 | 0001628280-26-061834 | EDGAR | 1K words |
| 2026-07-30 | 0001628280-26-051051 | EDGAR | 2K words |
| 2026-07-13 | 0001628280-26-048023 | EDGAR | 3K words |
| 2026-03-05 | 0001628280-26-015159 | EDGAR | 2K words |
| 2026-01-26 | 0001437749-26-002072 | EDGAR | 1K words |
| 2025-12-15 | 0001437749-25-037842 | EDGAR | 23K words |
| 2025-12-11 | 0001437749-25-037547 | EDGAR | 1K words |
| 2025-11-20 | 0001437749-25-035860 | EDGAR | 1K words |
| 2025-10-30 | 0001437749-25-032422 | EDGAR | 3K words |
42 total filings indexed. 22 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0001855175 |
| Ticker | CTNM |
| Exchange | Nasdaq |
| SIC | 2834: Pharmaceutical Preparations |
| Incorporated | DE |
| Website | https://www.contineum-tx.com |
| Listed | 2024-04-05 |
This is a static snapshot. For live, structured JSON with cryptographic provenance chain:
MCP (recommended for AI): claude mcp add origin --transport http https://origin.rootz.global/mcp
Try it — paste this into your AI:
Works in ChatGPT, Claude, Gemini, or any AI. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.
claude mcp add origin --transport http https://origin.rootz.global/mcpGET https://origin.rootz.global/api/company/CTNM (~200 tokens, structured JSON with cryptographic provenance)